Category: Medicine

Medicine

Gene editing startup Metagenomi files for an IPO

Dive Brief: Metagenomi, a biotechnology startup working to identify new CRISPR enzymes for editing genes, has filed to go public.

Medicine

FDA authorizes Florida to import drugs from Canada

For the first time, the Food and Drug Administration has authorized a U.S. state to import prescription drugs from Canada,

Medicine

An unusual drugmaker raises north of $100M for ecstasy-based PTSD therapy

A California-based company has raised tens of millions of dollars to support its mission of bringing an ecstasy-based therapy to

Medicine

Intellia to lay off staff, cut some early research

CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some

Medicine

Lilly launches online service for home delivery of weight loss drug

Dive Brief: Eli Lilly wants to make it easier for people to access its medicines for obesity, diabetes and migraine,

Medicine

Goldman Sachs gets into biotech investing with new venture fund

Dive Brief: Goldman Sachs Asset Management has wrapped up fundraising for the first fund in its Life Sciences investment venture,

Medicine

Pfizer wins Canadian OK for hemophilia treatment, its first gene therapy

Dive Brief: Canada’s health regulators have approved Pfizer’s gene therapy for hemophilia B, the company said Wednesday, making it the

Medicine

Novartis deepens ties with Voyager via $100M gene therapy deal

Dive Brief: Swiss pharmaceutical company Novartis has formed a new collaboration with partner Voyager Therapeutics, agreeing Tuesday to license one

Medicine

Tome acquires startup Replace, gaining new genome editing tools

Tome Biosciences has acquired biotechnology company Replace Therapeutics in a deal that gives the well-funded startup new tools to edit

Medicine

As ALS research booms, one treatment center finds itself in the spotlight

Merit Cudkowicz has spent her career treating some of the most unforgiving illnesses. She’s watched Alzheimer’s disease steal memories and

Medicine

Sanofi scraps a top ADC prospect after study setback

Dive Brief: Sanofi will stop developing one of its top cancer drug prospects after the experimental treatment fell short in

Medicine

BioMarin strikes deal with Elliott, agrees to review business

Dive Brief: Weeks after installing a new CEO, BioMarin Pharmaceutical is overhauling oversight of the company at the board level.

Medicine

Ionis, Astrazeneca win FDA approval of competitor to Alnylam drug

Dive Brief: The Food and Drug Administration on Thursday approved a new medicine for a form of the rare disease

Medicine

Bristol Myers to acquire brain drug developer Karuna for $14B

Bristol Myers Squibb has agreed to acquire Karuna Therapeutics for $14 billion, betting that the biotechnology company’s experimental schizophrenia drug

Medicine

Sarepta tests FDA flexibility with bid to expand Duchenne gene therapy’s approval

Sarepta Therapeutics has asked the Food and Drug Administration to expand approval of its gene therapy for Duchenne muscular dystrophy,

Medicine

J&J bets bigger on MeiraGTx’s eye gene therapy

Dive Brief: Gene therapy developer MeiraGTx is selling its remaining financial interest in an eye-disease treatment partnered with Johnson &

Medicine

Clene says its ALS drug data is not yet enough for FDA

Dive Brief: Clene Nanomedicine on Thursday said the Food and Drug Administration doesn’t believe the company has gathered enough evidence

Medicine

Argenx autoimmune drug study fails in blow to expansion hopes

Dive Brief: Argenx lost a quarter of its value Wednesday after reporting the second research setback in two months for

Medicine

GSK adds to ADC dealmaking with second Chinese biotech pact

Dive Brief: GSK is deepening its investment in cancer treatments called antibody-drug conjugates, announcing Wednesday plans to pay $185 million

Medicine

Investors still aren’t sold on UniQure’s gene therapy for Huntington’s

Dive Brief: Shares of UniQure dipped more than 10% Tuesday morning after the biotechnology company released more data from a

Medicine

Illumina to part with Grail, ending battle with regulators

Dive Brief: DNA sequencing company Illumina said Sunday it will divest Grail, the liquid biopsy maker it fought to hang

Medicine

Foundation behind Novo Nordisk to invest $260M in vaccine R&D

Dive Brief: The Novo Nordisk Foundation, which owns a controlling stake in drugmaker Novo Nordisk, said Monday it will invest

Medicine

Pivotal Life Sciences reloads with $389M, hunting for deals in a downturn

Dive Brief: Venture capital group Pivotal Life Sciences has raised its second fund, securing $389 million to invest in young

Medicine

Vir to lay off staff, cut costs amid setbacks building on COVID success

Dive Brief: Vir Biotechnology on Thursday announced a restructuring that will result in a 12% reduction in its workforce as

Medicine

Amgen finds a new top scientist in Novartis veteran Bradner

Amgen has a new top scientist, announcing Thursday the appointment of Novartis veteran and prolific biotechnology startup founder Jay Bradner

Medicine

European regulators push Biogen, CRISPR drugs toward approval

The committee that recommends whether drugs should be approved in Europe has thrown its support behind the first medicine based

Medicine

FDA widens use of cancer drug Merck acquired for $1B

Dive Brief: The Food and Drug Administration on Thursday broadened use of a drug Merck & Co. acquired in a